ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2–specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report
Title:
ALVR109, an off-the-shelf partially HLA matched SARS-CoV-2–specific T cell therapy, to treat refractory severe COVID-19 pneumonia in a heart transplant patient: Case report
Author:
Martits-Chalangari, Katalin Spak, Cedric W. Askar, Medhat Killian, Aaron Fisher, Tammy L. Atillasoy, Ercem Marshall, William L. McNeel, David Miller, Michael D. Mathai, Susan K. Gottlieb, Robert L.
Appeared in:
American journal of transplantation
Paging:
Volume 22 () nr. 4 pages 1261-1265
Year:
2022
Contents:
Publisher:
American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved.